Skip to main content
. 2020 Sep 30;11:575488. doi: 10.3389/fimmu.2020.575488

FIGURE 7.

FIGURE 7

Identification of novel functional markers of immune-modulatory UC.MSC. (A) Expression of CD146, CD271, and CD276 in UC-MSC under basal conditions or exposed to activated PBMNC for 5 days. (B) Expression of adhesion molecules CD106, CD54, CD44, CD49f, and CD49e in UC-MSC under basal conditions or exposed to activated PBMNC in cell contact (cc) or transwell (tw) setting for 5 days (* vs. Basal, p < 0.05, n = 4–6). (C) Detection of IL-2R in cell membrane, intracellular and in supernatants of UC-MSC treated with PHA, αCD3/CD28, TNFα/IL1b (CK), PHA and αCD3/CD28-activated PBMNC/MSC (* vs. Basal, p < 0.05, n = 4–6).